findmyKOL

Shamik Bhattacharyya, MD

Basic profile

Brigham and Women's Hospital

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shamik Bhattacharyya is a Neurology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 162 publications with 3,467 citations (h-index 24).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
162publications

Distinct works indexed by OpenAlex, matched via ORCID.

3,467citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

75 Francis St
Boston, MA 021156110

Telephone

617-732-7432

Provider last certified this registry record 10 Nov 2025.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    55.4%
    Gabapentinoids38.7%
    Gabapentin84%Pregabalin16%
    Part D<11 patients
    Opioid Agonist5.7%
    Fentanyl50%Hydromorphone Hcl50%
    Part D<11 patients

    + 4 more classes in this area

  • Musculoskeletal

    22.8%
    gamma-Aminobutyric Acid-ergic Agonist12.6%
    Baclofen100%
    Part D17 patients
    Muscle Relaxant7.8%
    Cyclobenzaprine Hcl100%
    Part D<11 patients

    + 1 more class in this area

  • Cancer & immunology

    13.7%
    CD20-directed Cytolytic Antibody5.9%
    Kesimpta Pen100%
    Part D<11 patients
    Pyrimidine Synthesis Inhibitor5.2%
    Teriflunomide100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)73.8% facility · 26.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”